Literature DB >> 24250952

The Effects of Enhanced External Counterpulsation on Cardiac Electrophysiologic Properties of Patients with Ischemic Heart Disease and Refractory Angina at Function Class II-III.

Fariborz Akbarzadeh1, Yaghoub Salekzamani, Amir Shahram Beigzdeh.   

Abstract

INTRODUCTION: Enhanced external counterpulsation (EECP) is a noninvasive circulatory assist device that has been recently emerged as a treatment option for refractory angina or left ventricular (LV) dysfunction. The aims of this study were to examine the effects of EECP on the elecrocardiographic parameters and the heart rate variability indices of patients with the coronary heart disease and function class II-III angina resistant to medication.
METHODS: In a descriptive study, the patients who presented with sever angina at function class II-III were studied. Those meeting the inclusion criteria were invited to participate and provided informed consent. The standard enhanced external counterpulsation treatment (35 one-hour procedures 5-6 times a week) was done. Thirty minute ambulatory electrocardiographic monitoring and electrocardiogram before starting and at the end of treatment sessions were done. Data entry and analysis of data was done finally.
RESULTS: Twenty five patients with mean age 68±9 year including 21(84%) men and 4(16%) women were enrolled in this study. Electocardiogarphic parameters before and after treatment by EECP were not different statistically. Time domain indices of heart rate variability according to ambulatory monitoring findings were not changed significantly.
CONCLUSION: Results of this study revealed that EECP did not improve the electrocardiographic and heart rate variability parameters of ischemic heart disease patients with refractory angina at function class II or III.

Entities:  

Keywords:  Electrocardiography; External Countrapulsation; Heart rate variability

Year:  2011        PMID: 24250952      PMCID: PMC3825325          DOI: 10.5681/jcvtr.2011.010

Source DB:  PubMed          Journal:  J Cardiovasc Thorac Res        ISSN: 2008-5117


  5 in total

1.  Treating heart failure with enhanced external counterpulsation (EECP): design of the Prospective Evaluation of EECP in Heart Failure (PEECH) trial.

Authors:  Arthur M Feldman; Marc A Silver; Gary S Francis; Paul-André De Lame; William W Parmley
Journal:  J Card Fail       Date:  2005-04       Impact factor: 5.712

2.  Improved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effect?

Authors:  W E Lawson; J C Hui; Z S Zheng; L Burgen; L Jiang; O Lillis; Z Oster; H Soroff; P Cohn
Journal:  Cardiology       Date:  1996 Jul-Aug       Impact factor: 1.869

3.  Course and prognostic implications of QT interval and QT interval variability after primary coronary angioplasty in acute myocardial infarction.

Authors:  H Bonnemeier; F Hartmann; U K Wiegand; F Bode; H A Katus; G Richardt
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

4.  Sequential external counterpulsation (SECP) in China.

Authors:  Z S Zheng; T M Li; H Kambic; G H Chen; L Q Yu; S R Cai; C Y Zhan; Y C Chen; S X Wo; G W Chen
Journal:  Trans Am Soc Artif Intern Organs       Date:  1983

5.  The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes.

Authors:  R R Arora; T M Chou; D Jain; B Fleishman; L Crawford; T McKiernan; R W Nesto
Journal:  J Am Coll Cardiol       Date:  1999-06       Impact factor: 24.094

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.